TRYPTOPHAN MALABSORPTION IN LEVODOPA‐TREATED PARKINSONIAN PATIENTS
- 12 January 1973
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 194 (1-6) , 181-189
- https://doi.org/10.1111/j.0954-6820.1973.tb19428.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- LEVODOPA AND DEPRESSION IN PARKINSONISMThe Lancet, 1971
- 5-HYDROXYTRYPTOPHAN IN PARKINSONISMThe Lancet, 1970
- The effect of L-Dopa on monoamine metabolites in Parkinson's diseaseCellular and Molecular Life Sciences, 1970
- ORAL L‐DOPA TREATMENT OF PARKINSONISMActa Medica Scandinavica, 1970
- Studies on the uptake of radiolabeled DOPA, 5-HTP and tryptophan in rat tissuesin vivo: Effect of methionine, tryptophan and some keto acidsInternational Journal of Neuropharmacology, 1968
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from ParkinsonismStereotactic and Functional Neurosurgery, 1967
- MENTAL DISTRUBANCES FOLLOWED BY STUPOR IN A PATIENT WITH CARCINOIDOSIS: Recovery with Tryptophan treatmentActa Psychiatrica Scandinavica, 1966
- A relationship between blood serotonin concentrations and behavior in psychiatric patientsJournal of Psychiatric Research, 1965
- Disorders of Amino-Acid TransportBMJ, 1964